Medpace appoints Dr. Femida H. Gwadry-Sridhar as new Class I director

Medpace Holdings, Inc.

Dr. Gwadry-Sridhar appointed to Board effective Jan 16, 2023, filling a Class I vacancy.
She is CEO of Pulse Infoframe, a real-world evidence company, with academic roles at Western University and USC.
Received an option to purchase 573 shares at Jan 13 closing price, with 7-year term.
Expected to serve on the Nominating and Governance Committee.
Participates in standard non-employee director compensation program.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Femida H. Gwadry-Sridhar

Class I Director

MEDP · Medpace Holdings, Inc.

Effective: 2023-01-16
Filed: January 18, 2023, 6:59 PM ET

unanimously approved that Dr. Femida H. Gwadry-Sridhar be elected to fill the Class I director vacancy on the Board of the Company, effective January 16, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Femida H. Gwadry-Sridhar was elected as Class I Director at Medpace Holdings, Inc..

Action: elected
Role: Class I Director

Exact text from the filing

unanimously approved that Dr. Femida H. Gwadry-Sridhar be elected to fill the Class I director vacancy on the Board of the Company, effective January 16, 2023

View on SEC.gov

Medpace Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-010261

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.